Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
ImmunoGen, Inc.
Scientific Title
A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (PICCOLO)